Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma

Despite of the discovery of protein therapeutic targets and advancement in multimodal therapy, the survival chance of high-risk neuroblastoma (NB) patients is still less than 50%. MYCN amplification is a potent driver of NB, which exerts its oncogenic activity through either activating or inhibiting...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahu, Divya, Hsu, Chia-Lang, Lin, Chen-Ching, Yang, Tz-Wen, Hsu, Wen-Ming, Ho, Shinn-Ying, Juan, Hsueh-Fen, Huang, Hsuan-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295409/
https://www.ncbi.nlm.nih.gov/pubmed/27517149
http://dx.doi.org/10.18632/oncotarget.11158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295409/
https://www.ncbi.nlm.nih.gov/pubmed/27517149
http://dx.doi.org/10.18632/oncotarget.11158

Ejemplares similares